Vessel-sparing Technique Versus Conventional Repair of PFUI: A Prospective Comparative Study
Launched by ASSIUT UNIVERSITY · Jan 31, 2024
Trial Information
Current as of September 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for treating men who have a specific type of injury to the urethra caused by pelvic fractures, known as pelvic fracture urethral injury (PFUI). One method is the traditional repair, which involves some complex steps that can sometimes lead to problems with blood flow to the urethra. The other method is a newer technique that aims to preserve the blood vessels during the repair, which may help improve recovery and function after surgery. The goal of this study is to see if the vessel-sparing technique is more effective than the conventional repair method.
To participate in this trial, men aged 18 and older with PFUI may be eligible, but those with previous surgeries or recurrent cases will not qualify. Participants can expect to undergo one of the two surgical techniques and will be monitored to see how well they recover and if there are any differences in outcomes between the two methods. This study is still in the planning stages and has not yet started recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • - Adult male patients ≥ 18 years old with PFUI
- Exclusion Criteria:
- • Recurrent cases. • History of concomitant bladder neck injury
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported